On Sep 1, 2021 Asher Bio closed a Series B round and raised $108,000,000 from Alexandria Venture Investments, Boxer Capital, Invus, Janus Henderson Investors, Logos […]
Series B – Asher Bio
On Sep 1, 2021 Asher Bio closed a Series B round and raised $108,000,000 from Alexandria Venture Investments, Boxer Capital, Invus, Janus Henderson Investors, Logos […]
2bPrecise acquired by AccessDX
Aug 25, 2021 AccessDX has entered into an agreement to acquire 2bPrecise . AccessDX based at Houston, Texas, United States. “Learn why 2,000+ healthcare organizations […]
Series B – Immunitas Therapeutics
On Aug 18, 2021 Immunitas Therapeutics closed a Series B round and raised $58,000,000 from 120 Capital Management, Agent Capital, Alexandria Venture Investments, BrightEdge Fund, […]
Series A – LQT Therapeutics
On Aug 10, 2021 LQT Therapeutics closed a Series A round and raised $19,000,000 from Alexandria Venture Investments, Amplitude Venture Capital, Amzak Health Investors, Fonds […]
Vividion Therapeutics acquired by Bayer
Aug 5, 2021 Bayer has entered into an agreement to acquire Vividion Therapeutics in a $1,500,000,000 deal. Bayer based at Leverkusen, Nordrhein-Westfalen, Germany. “We exist […]
Series B – Aardvark Therapeutics
On Aug 5, 2021 Aardvark Therapeutics closed a Series B round and raised $29,000,000 from BNH, Korea Omega Investment, Premier Partners, Sorrento Therapeutics, The Foundation […]
Seed Round – Sharper Sense
On Aug 1, 2021 Sharper Sense closed a Seed round and raised $425,000 from Cornell Tech, Joyance Partners, featuring lead investors . About the company: […]
Seed Round – Macomics
On Jul 29, 2021 Macomics closed a Seed round and raised £4,240,000 from Caribou Property, Epidarex Capital, Scottish Enterprise, featuring lead investors Epidarex Capital. About […]
Series D – Rakuten Medical
On Jul 29, 2021 Rakuten Medical closed a Series D round and raised $166,000,000 from General Catalyst, Rakuten Capital, SBI Group, featuring lead investors General […]
